These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8980758)

  • 41. In vitro susceptibility of Chlamydia pecorum to macrolides, tetracyclines, quinolones and beta-lactam.
    Pudjiatmoko ; Fukushi H; Ochiai Y; Yamaguchi T; Hirai K
    Microbiol Immunol; 1998; 42(1):61-3. PubMed ID: 9525782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
    Jones RN; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):119-26. PubMed ID: 9823536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
    Gootz TD; Zaniewski R; Haskell S; Schmieder B; Tankovic J; Girard D; Courvalin P; Polzer RJ
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2691-7. PubMed ID: 9124824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
    Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of recent antibacterial agents against bacteria causing diarrhoea.
    Bergan T; Lolekha S; Cheong MK; Poh CL; Doencham S; Charoenpipop D
    Scand J Infect Dis Suppl; 1988; 56():7-10. PubMed ID: 3266900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
    Jones RN; Barrett MS; Deguchi T
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.
    Kim HY; Rikihisa Y
    J Clin Microbiol; 1998 Nov; 36(11):3278-84. PubMed ID: 9774579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative in vitro activities of trovafloxacin (CP-99,219) against 445 gram-positive isolates from patients with endocarditis and those with other bloodstream infections.
    Endtz HP; Mouton JW; den Hollander JG; van den Braak N; Verbrugh HA
    Antimicrob Agents Chemother; 1997 May; 41(5):1146-9. PubMed ID: 9145886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of cattle to infection with Ehrlichia equi and the agent of human granulocytic ehrlichiosis.
    Pusterla N; Anderson RJ; House JK; Pusterla JB; DeRock E; Madigan JE
    J Am Vet Med Assoc; 2001 Apr; 218(7):1160-2. PubMed ID: 11318369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):33-8. PubMed ID: 9990473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human ehrlichiosis in central Europe.
    Lotric-Furlan S; Petrovec M; Avsic-Zupanc T; Nicholson WL; Sumner JW; Childs JE; Strle F
    Wien Klin Wochenschr; 1998 Dec; 110(24):894-7. PubMed ID: 10048172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of new quinolones against Clostridium difficile.
    Alonso R; Peláez T; González-Abad MJ; Alcalá L; Muñoz P; Rodríguez-Créixems M; Bouza E
    J Antimicrob Chemother; 2001 Feb; 47(2):195-7. PubMed ID: 11157906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
    Cornaglia G; Ligozzi M; Pelosi E; Canepari P; Fontana R
    J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents.
    Unver A; Felek S; Paddock CD; Zhi N; Horowitz HW; Wormser GP; Cullman LC; Rikihisa Y
    J Clin Microbiol; 2001 Nov; 39(11):3982-6. PubMed ID: 11682518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species.
    MacGowan AP; Holt HA; Bywater MJ; Reeves DS
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):767-70. PubMed ID: 2124539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Hecht DW; Osmolski JR
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serologic and clinical evidence for endemic occurrences of human granulocytic ehrlichiosis in North-Eastern Switzerland].
    Weber R; Pusterla N; Loy M; Leutenegger CM; Schär G; Baumann D; Wolfensberger C; Lutz H
    Schweiz Med Wochenschr; 2000 Oct; 130(41):1462-70. PubMed ID: 11075410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.